Salto-Tellez M - Search Results

1

RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression.

Subramaniam MM, Chan JY, Soong R, Ito K, Ito Y, Yeoh KG, Salto-Tellez M, Putti TC. Subramaniam MM, et al. Breast Cancer Res Treat. 2009 Jan;113(1):113-21. doi: 10.1007/s10549-008-9917-4. Epub 2008 Feb 7. Breast Cancer Res Treat. 2009. PMID: 18256927

2

RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization.

Ito K, Liu Q, Salto-Tellez M, Yano T, Tada K, Ida H, Huang C, Shah N, Inoue M, Rajnakova A, Hiong KC, Peh BK, Han HC, Ito T, Teh M, Yeoh KG, Ito Y. Ito K, et al. Cancer Res. 2005 Sep 1;65(17):7743-50. doi: 10.1158/0008-5472.CAN-05-0743. Cancer Res. 2005. PMID: 16140942

3

RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer.

Lau QC, Raja E, Salto-Tellez M, Liu Q, Ito K, Inoue M, Putti TC, Loh M, Ko TK, Huang C, Bhalla KN, Zhu T, Ito Y, Sukumar S. Lau QC, et al. Cancer Res. 2006 Jul 1;66(13):6512-20. doi: 10.1158/0008-5472.CAN-06-0369. Cancer Res. 2006. PMID: 16818622

4

RUNX3 inactivation in colorectal polyps arising through different pathways of colonic carcinogenesis.

Subramaniam MM, Chan JY, Soong R, Ito K, Yeoh KG, Wong R, Guenther T, Will O, Chen CL, Kumarasinghe MP, Ito Y, Salto-Tellez M. Subramaniam MM, et al. Am J Gastroenterol. 2009 Feb;104(2):426-36. doi: 10.1038/ajg.2008.141. Epub 2009 Jan 27. Am J Gastroenterol. 2009. PMID: 19174785

5

Molecular pathology of RUNX3 in human carcinogenesis.

Subramaniam MM, Chan JY, Yeoh KG, Quek T, Ito K, Salto-Tellez M. Subramaniam MM, et al. Biochim Biophys Acta. 2009 Dec;1796(2):315-31. doi: 10.1016/j.bbcan.2009.07.004. Epub 2009 Aug 12. Biochim Biophys Acta. 2009. PMID: 19682550 Free article. Review.

6

MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer.

Lai KW, Koh KX, Loh M, Tada K, Subramaniam MM, Lim XY, Vaithilingam A, Salto-Tellez M, Iacopetta B, Ito Y, Soong R; Singapore Gastric Cancer Consortium. Lai KW, et al. Eur J Cancer. 2010 May;46(8):1456-63. doi: 10.1016/j.ejca.2010.01.036. Epub 2010 Feb 20. Eur J Cancer. 2010. PMID: 20176475

7

Lack of RUNX3 inactivation in columnar cell lesions of breast.

Subramaniam MM, Chan JY, Omar MF, Ito K, Ito Y, Yeoh KG, Salto-Tellez M, Putti TC. Subramaniam MM, et al. Histopathology. 2010 Oct;57(4):555-63. doi: 10.1111/j.1365-2559.2010.03675.x. Histopathology. 2010. PMID: 20955380

8

The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome.

Soong R, Shah N, Peh BK, Chong PY, Ng SS, Zeps N, Joseph D, Salto-Tellez M, Iacopetta B, Ito Y. Soong R, et al. Br J Cancer. 2009 Mar 10;100(5):676-9. doi: 10.1038/sj.bjc.6604899. Epub 2009 Feb 17. Br J Cancer. 2009. PMID: 19223906 Free PMC article.

9

Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.

Chen W, Salto-Tellez M, Palanisamy N, Ganesan K, Hou Q, Tan LK, Sii LH, Ito K, Tan B, Wu J, Tay A, Tan KC, Ang E, Tan BK, Tan PH, Ito Y, Tan P. Chen W, et al. Genes Chromosomes Cancer. 2007 Mar;46(3):288-301. doi: 10.1002/gcc.20411. Genes Chromosomes Cancer. 2007. PMID: 17171680

10

Clonal characterization of sporadic cribriform-morular variant of papillary thyroid carcinoma by laser microdissection-based APC mutation analysis.

Subramaniam MM, Putti TC, Anuar D, Chong PY, Shah N, Salto-Tellez M, Soong R. Subramaniam MM, et al. Am J Clin Pathol. 2007 Dec;128(6):994-1001. doi: 10.1309/YXR3PKK4TV3DJC56. Am J Clin Pathol. 2007. PMID: 18024325

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

321 results

Search Page